Simcyp Consortium

At a Glance
  • Status: Active Consortium
  • Year Launched: 2001
  • Initiating Organization: Simcyp
  • Initiator Type: Industry
  • No disease focus
  • Location: Europe
simcyp logo


The Simcyp Consortium develops a user-friendly platform designed specifically to allow for simulations in representative virtual patient populations based on in vitro and clinical data. The Simcyp Population-based Simulator includes extensive demographic, physiologic, and genomic databases, which have allowed Simcyp to develop algorithms that account for patient variability. This enables the user to predict drug behavior in the virtual patient population, as opposed to a virtual reference man, allowing individuals at extreme risk to be identified. Currently, 70 percent of the top-40 pharma companies (including all of the top 10) are members of the Simcyp Consortium.


The Simcyp Population-based Simulator streamlines drug development through the modeling and simulation of pharmacokinetics (PK) and pharmacodynamics (PD) in virtual populations. The Simulator is the pharmaceutical industry’s most sophisticated platform for the prediction of drug-drug interactions and pharmacokinetic outcomes in clinical populations.

It incorporates numerous databases containing human physiological, genetic, and epidemiological information. By integrating this information with in vitro or clinical data, the Simulator allows for prediction of PK/PD behavior in “real-world” populations. This automated prediction of in vivo outcomes accelerates the assessment of large numbers of compounds, saving time and cost.

The Simulator provides valuable information for key management decisions relating to clinical trial design, clinical trial avoidance, and drug-drug interaction (DDI) information for the Summary of Product Characteristics (SPCs) and Prescribing Information sheets.

The Simulator can also identify key preclinical data requirements, which can prove extremely valuable for redefining and optimizing early drug development processes and procedures.

Structure & Governance

Simcyp receives guidance from a board of world-renowned, independent scientists who are active in relevant research areas.


Each year, consortium members are invited to a meeting at which they provide feedback on their use of the Simulator and suggest any features/improvements that they would like added to the platform.

At each meeting, the Simcyp team presents updates to the databases and Simulator as well as proposals for further development. The consortium members agree on and prioritize a list of features for the Simcyp team to work on.

Consortium members receive all new releases of the Simulator and have access to the Simcyp science team for consultancy on specific issues.

Each year consortium members are invited to Focus Group Meetings and webinars, which tackle specific problems in the area of in vitro-in vivo extrapolation (IVIVE).

The Simcyp team has received several awards over the years including the following:

Points of Contact

Simcyp Limited
Blades Enterprise Centre
John Street
Sheffield S2 4SU
phone: +44 (0) 114 292 2322
fax: +44 (0) 114 292 2333

Sponsors & Partners



Cincinnati Children’s Hospital Medical Center


Dainippon Sutmitomo


Eli Lilly

F. Hoffman-La Roche

Finders University of South Australia

Ghent University

Gruenthal GmbH

Indiana University

Johannes Gutenberg-University

Johnson & Johnson Pharmaceutical Research and Development

Keio University

Leiden University


Medical Products Agency (MPA)

Merck KGaA Germany

Novartis Pharma


Peking Union Medical College (PUMC)


Radboud University Nijmegen



Showa Pharmaceutical University


The Hamner Institutes for Health Sciences

U.S. Environmental Protection Agency


University at Buffalo

University of Bath

University of Copenhagen

University of Florida

University of Helsinki

University of Manchester

University of North Carolina

University of Uppsala

University of Washington

Last Updated: 04/22/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.